Drugs & medicalClass II

PD-Rx Pharmaceuticals, Inc. recalls Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK…

CGMP deviations.

Read the official notice →
Date
2023-05-10
Country
United States
Brand
PD-Rx Pharmaceuticals
Product
Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127,…
Classification
Class II
Units
Nationwide in the US.
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More PD-Rx Pharmaceuticals recalls

  1. 2025-01-01
  2. US
    Drugs & medicalClass II

    PD-Rx Pharmaceuticals, Inc. recalls DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceuticals Inc, Oklahoma City, OK 73127, NDC: 43063-877-90

    CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Duloxetine above the interim acceptable intake limit

    FDA · DrugPD-Rx Pharmaceuticals, Inc.Distributed within US: FL, MS, WIOfficial notice →
  3. 2022-07-06
  4. US
    Drugs & medicalClass II

    PD-Rx Pharmaceuticals, Inc. recalls Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and Packaged By: PD-Rx Pharmaceuticals, Inc. Oklahoma…

    CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits

    FDA · DrugPD-Rx Pharmaceuticals, Inc.NationwideOfficial notice →
All 3 PD-Rx Pharmaceuticals recalls →

Other drugs & medical recalls in the United States

  1. 2023-05-10
  2. US
    Drugs & medicalClass I

    Gadget Island, Inc recalls DYNAMITE SUPER capsule, 58,000 MG, 1-count blister card, Made in America, UPC 6 75799 37602 7.

    Marketed without an Approved NDA/ANDA: FDA analysis found product to be tainted with undeclared sildenafil and tadalafil, ingredients found in FDA approved products for the treatment of male sexual enhancement, making…

    FDA · DrugGadget Island, IncNationwide in the USA.Official notice →
  3. US
    Drugs & medicalClass II

    Family Dollar Stores, Llc. recalls Advil Ibuprofen Tablets, 200 mg Pain Reliever/Fever Reducer (NSAID) 24-count Caplets

    CGMP deviation: product outside labeled storage temperature requirements.

    FDA · DrugFamily Dollar Stores, Llc.Nationwide within the United StatesOfficial notice →
  4. US
    Drugs & medicalClass II

    Seatex LLC recalls Seatex Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-Sterile Solution Net Contents: 3.785 L (1 Gallon) Container, UPC 6 12592…

    Superpotent Drug and Failed Impurities/Degradation Products: formula does not adhere to the labeled specifications

    FDA · DrugSeatex LLCFL, GA, TXOfficial notice →
  5. US
    Drugs & medicalClass III

    Bryant Ranch Prepack, Inc. recalls Lidocaine Patch 5%, 1 patch (63629-8755-20) packaged in 30-count patches per carton (63629-8755-1), Rx only, each patch contains: 700…

    Labeling: Typographical error on the upper left-hand side of the box and individual patch label that has the incorrect dosage form stating, each tablet contains instead of each adhesive patch contains.

    FDA · DrugBryant Ranch Prepack, Inc.Nationwide in the USAOfficial notice →
  6. 2023-05-04
  7. US
    Drugs & medical

    Walker Edison Furniture Recalls Twin Over Twin Bunk Beds Due to Fall and Impact Hazards

    The wooden slats supporting the bunk beds can break while in use, posing fall and impact hazards.

    CPSCAbout 121,000Official notice →
  8. 2023-05-03
  9. US
    Drugs & medicalClass II

    Draeger Medical Systems, Inc. recalls Draeger Infinity M300 and M300+, for use with the ICS to monitor ECG and pulse oximetry on ambulatory and non-ambulatory adult and…

    The software on the Infinity CentralStation drops peaks on narrow waveforms causing the Infinity M300 to fail to meet Frequency and Impulse Response requirements. In this condition, ECG waveforms with unusually narrow…

    FDA · DeviceDraeger Medical Systems, Inc.Worldwide - US Nationwide distribution.Official notice →
See all drugs & medical recalls →